Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed

Qiang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0096-7679; OpenAlex author ID A5034017799. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 3

  1. Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein. Co-author DOI 10.7150/thno.30988↗
  2. WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells. Co-author DOI 10.1016/s1499-3872(14)60277-0↗
  3. MTHFR C677T polymorphism and pancreatic cancer risk: a meta-analysis. Last author DOI 10.7314/apjcp.2012.13.8.3763↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shi-Jiang Deng · 1 shared paper, 2019 · strength 0.09
  2. Fengyu Xu · 1 shared paper, 2019 · strength 0.09
  3. Ye Zeng · 1 shared paper, 2019 · strength 0.09
  4. Mingliang Liu · 1 shared paper, 2019 · strength 0.09
  5. Gang Zhao · 1 shared paper, 2019 · strength 0.09
  6. Zhu Zeng · 1 shared paper, 2019 · strength 0.09
  7. Xiao-Hong Shen · 1 shared paper, 2014 · strength 0.05
  8. Wei Wei · 1 shared paper, 2014 · strength 0.05
  9. Xiang-Ming Liu · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.